Protalix BioTherapeutics (PLX) EV to FCF (2018 - 2026)
Protalix BioTherapeutics' (PLX) EV to FCF stood at 19.18 in Q2 2026, up 101.4% from the prior quarter.
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EV to FCF (2018 - 2026) Analysis & Trends
On a TTM basis, Protalix BioTherapeutics' EV to FCF came in at 4.74 as of Jun 30, 2026; for FY2024, it was 14.58.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Protalix BioTherapeutics | 207.16 Mn | 55.78 Mn | 12.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19.18 |
| Mar 31, 2026 | 9.52 |
| Dec 31, 2024 | 14.58 |
| Sep 30, 2024 | 6.65 |
| Mar 31, 2024 | 10.05 |
| Sep 30, 2018 | 5.04 |
API Access
Protalix BioTherapeutics EV to FCF API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=PLX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-fcf", "ticker": "PLX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=PLX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();